112 related articles for article (PubMed ID: 11936353)
21. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
Fowler VG; Boucher HW; Corey GR; Abrutyn E; Karchmer AW; Rupp ME; Levine DP; Chambers HF; Tally FP; Vigliani GA; Cabell CH; Link AS; DeMeyer I; Filler SG; Zervos M; Cook P; Parsonnet J; Bernstein JM; Price CS; Forrest GN; Fätkenheuer G; Gareca M; Rehm SJ; Brodt HR; Tice A; Cosgrove SE;
N Engl J Med; 2006 Aug; 355(7):653-65. PubMed ID: 16914701
[TBL] [Abstract][Full Text] [Related]
22. New agents for Staphylococcus aureus endocarditis.
Drees M; Boucher H
Curr Opin Infect Dis; 2006 Dec; 19(6):544-50. PubMed ID: 17075329
[TBL] [Abstract][Full Text] [Related]
23. Treatment of bacteraemia: meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin-resistant S. aureus (VRSA).
Gould IM
Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S17-21. PubMed ID: 23664580
[TBL] [Abstract][Full Text] [Related]
24. Glycopeptides in the treatment of staphylococcal infections.
Daschner FD; Kropec A
Eur J Clin Microbiol Infect Dis; 1995; 14 Suppl 1():S12-7. PubMed ID: 7729466
[TBL] [Abstract][Full Text] [Related]
25. Management of methicillin-resistant Staphylococcus aureus bacteremia.
Cosgrove SE; Fowler VG
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S386-93. PubMed ID: 18462094
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of mitral MRSA endocarditis using daptomycin].
Senneville E; Beltrand E; Legout L; Leroy O; Fayad G
Med Mal Infect; 2008 Dec; 38 Spec No 2():13-5. PubMed ID: 19185204
[No Abstract] [Full Text] [Related]
27. [Acquired data on the antibiotic treatment of bacterial endocarditis on native or prosthetic valves].
Hoen B; Leport C; Carbon C
Rev Prat; 1993 Oct; 43(16):2112-7. PubMed ID: 8134795
[TBL] [Abstract][Full Text] [Related]
28. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin.
Fortún J; Navas E; Martínez-Beltrán J; Pérez-Molina J; Martín-Dávila P; Guerrero A; Moreno S
Clin Infect Dis; 2001 Jul; 33(1):120-5. PubMed ID: 11389505
[TBL] [Abstract][Full Text] [Related]
29. Management of bacterial endocarditis.
Giessel BE; Koenig CJ; Blake RL
Am Fam Physician; 2000 Mar; 61(6):1725-32, 1739. PubMed ID: 10750879
[TBL] [Abstract][Full Text] [Related]
30. Staphylococcus lugdunensis bacteremia and endocarditis treated with cefazolin and rifampin.
Duhon B; Dallas S; Velasquez ST; Hand E
Am J Health Syst Pharm; 2015 Jul; 72(13):1114-8. PubMed ID: 26092962
[TBL] [Abstract][Full Text] [Related]
31. Successful treatment of Staphylococcus epidermidis prosthetic valve endocarditis with linezolid after failure of treatment with oxacillin, gentamicin, rifampicin, vancomycin, and fusidic acid regimens.
de Feiter PW; Jacobs JA; Jacobs MJ; Vink C; van der Geest S
Scand J Infect Dis; 2005; 37(3):173-6. PubMed ID: 15849048
[TBL] [Abstract][Full Text] [Related]
32. The role of vancomycin in the treatment paradigm.
Stevens DL
Clin Infect Dis; 2006 Jan; 42 Suppl 1():S51-7. PubMed ID: 16323121
[TBL] [Abstract][Full Text] [Related]
33. Methicillin-resistant Staphylococcus aureus infection with intermediate sensitivity to vancomycin: a case report and literature review.
Schairer J; Sankri-Tarbichi AG; Fairfax MR; Salimnia H; Guzman JA
J Intensive Care Med; 2008; 23(5):338-41. PubMed ID: 18701528
[TBL] [Abstract][Full Text] [Related]
34. [Therapy and prevention of infectious endocarditis].
Horstkotte D; Rosin H
Schweiz Med Wochenschr; 1984 Nov; 114(45):1575-86. PubMed ID: 6515354
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of MRSA infections].
Borde JP; Kern WV
Dtsch Med Wochenschr; 2012 Dec; 137(49):2553-7. PubMed ID: 23143638
[No Abstract] [Full Text] [Related]
36. Infections of prosthetic heart valves and cardiac pacemakers.
Heimberger TS; Duma RJ
Infect Dis Clin North Am; 1989 Jun; 3(2):221-45. PubMed ID: 2663979
[TBL] [Abstract][Full Text] [Related]
37. Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infection.
Takata T; Miyazaki M; Futo M; Hara S; Shiotsuka S; Kamimura H; Yoshimura H; Matsunaga A; Nishida T; Ishikura H; Ishikawa T; Tamura K; Tsuji BT
Scand J Infect Dis; 2013 Mar; 45(3):203-12. PubMed ID: 23113753
[TBL] [Abstract][Full Text] [Related]
38. A mouse peritonitis model for the study of glycopeptide efficacy in GISA infections.
Domenech A; Ribes S; Cabellos C; Domínguez MA; Montero A; Liñares J; Ariza J; Gudiol F
Microb Drug Resist; 2004; 10(4):346-53. PubMed ID: 15650381
[TBL] [Abstract][Full Text] [Related]
39. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia.
Walraven CJ; North MS; Marr-Lyon L; Deming P; Sakoulas G; Mercier RC
J Antimicrob Chemother; 2011 Oct; 66(10):2386-92. PubMed ID: 21775337
[TBL] [Abstract][Full Text] [Related]
40. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
